Holders · period archive

ALLO · Allogene Therapeutics Inc.

Q2 2019 13F holders

← latest ownership dossier

Ticker: ALLO
Type: Equity
Class: COM
Total reported value ($000, long equity)

Manager	Report date	Value	Shares